Sonographic fatty liver and hepatitis B virus carrier status: Synergistic effect on liver damage in Taiwanese adults

World Journal of Gastroenterology

Volumn 13, Issue 12, 2007, Pages 1805-1810

  Lin, Yu Cheng ^a   Hsiao, Shu Tin ^b   Chen, Jong Dar ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Fatty liver; Hepatitis B virus; Sonography; Synergism

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CARRIER; ECHOGRAPHY; FATTY LIVER; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; LIVER FUNCTION TEST; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROPARTICLE ENZYME IMMUNOASSAY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STUDENT T TEST; TAIWAN; ULTRASOUND; VIRUS CARRIER;

EID: 34248222217     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i12.1805     Document Type: Article

References (54)

1. Limdi JK, Hyde GM. Evaluation of abnormal liver function tests. Postgrad Med J 2003; 79: 307-312
2. Gasbarrini G, Vero V, Miele L, Forgione A, Hernandez AP, Greco AV, Gasbarrini A, Grieco A. Nonalcoholic fatty liver disease: defining a common problem. Eur Rev Med Pharmacol Sci 2005; 9: 253-259
3. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000; 15: 1356-1361
4. Tam KM, Wu JS. Ultrasonographic diagnosis of fatty liver. Taiwan Yixuehui Zazhi 1986; 85: 45-53
5. Fan JG, Zhu J, Li XJ, Chen L, Lu YS, Li L, Dai F, Li F, Chen SY. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 2005; 20: 1825-1832
6. Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci 2005; 50: 171-180
7. Chang MH. Hepatitis B virus infection in children: epidemiology natural course and prevention in Taiwan. J Formos Med Assoc 1996; 95: 593-598
8. Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol 2005; 43: 38-44
9. Shabot JM, Jaynes C, Little HM Jr, Alperin JB, Snyder N. Viral hepatitis in pregnancy with dissen-tinated intravascular coagulation and hypoglycemia. South Med J 1978; 71: 479-481
10. Canbay A, Bechmann LP, Best J, Jochum C, Treichel U, Gerken G. Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure. Z Gastroenterol 2006; 44: 245-248
11. Yuen MF, Yuan HJ, Wong DK, Yuen JC, Wong WM, Chan AO, Wong BC, Lai KC, Lai CL. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 2005; 54: 1610-1614
12. Wong WM, Ho JC, Ooi GC, Mok T, Chan J, Hung IF, Ng W, Lam YM, Tam WO, Wong BC, Wong PC, Ho PL, Lai CL, Lam WK, Lam SK, Tsang KW. Temporal patterns of hepatic dysfunction and disease severity in patients with SARS. JAMA 2003; 290: 2663-2665
13. Chu NF. Prevalence of obesity in Taiwan. Obes Rev 2005; 6: 271-274
14. Katayama K, Hayashi N, Takehara T, Towata T, Kasahara A, Fusamoto H, Kamada T. Effects of alpha-interferon on gamma-interferon production of peripheral blood mononuclear cells in hepatitis B virus carriers. J Clin Immunol 1992; 12: 347-352
15. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750
16. Steinmaurer HJ, jirak P, Walchshofer J, Clodi PH. Accuracy of sonography in the diagnosis of diffuse liver parenchymal diseases - comparison of sonography and liver histology. Ultraschall Med 1984; 5: 98-103
17. Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139: 43-50
18. Lundberg M, Fredlund P, Hallqvist J, Diderichsen F. A SAS program calculating three measures of interaction with confidence intervals. Epidemiology 1996; 7: 655-656
19. Qu JB, Zhang ZW, Shimho S, Watanabe T, Nakatsuka H, Matsuda-Inoguchi N, Higashikawa K, Ikeda M. Urban-rural comparison of HBV and HCV infection prevalence in eastern China. Biomed Environ Sci 2000; 13: 243-253
20. Lonardo A, Carani C, Carulli N, Loria P. 'Endocrine NAFLD'a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J Hepatol 2006; 44: 1196-1207
21. Chowdhury A, Santra A, Chaudhuri S, Ghosh A, Banerjee P, Mazumder DN. Prevalence of hepatitis B infection in the general population: a rural community based study. Trop Gastroenterol 1999; 20: 75-77
22. Hopkirk N, Moyes CD, Lucas CR. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand. N Z Med J 2000; 113: 114-116
23. Tanaka J, Kumagai J, Katayama K, Komiya Y, Mizui M, Yamanaka R, Suzuki K, Miyakawa Y, Yoshizawa H. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000. Intervirology 2004; 47: 32-40
24. Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol 2006; 101 Supp] 1: Sl-S6
25. Choi S, Diehl AM. Role of inflammation in nonalcoholic steatohepatitis. Curr Opin Gastroenterol 2005; 21: 702-707
26. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539-543
27. Riley TR 3rd, Kahn A. Risk factors and ultrasound can predict chronic hepatitis caused by nonalcoholic fatty liver disease. Dig Dis Sci 2006; 51: 41-44
28. Colicchio P, Tarantino G, del Genio F, Sorrentino P, Saldalamacchia G, Finelli C, Conca P, Contaldo F, Pasanisi F. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. Ann Nutr Metab 2005; 49: 289-295
29. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D, Antonini TM, Alessandri C. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 2003; 18: 588-594
30. Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004; 53: 1494-1498
31. Seo Y, Yoon S, Truong BX, Kato H, Hamano K, Kato M, Yano Y, Katayama M, Ninon-dya T, Hayashi Y, Kasuga M. Serum hepatitis B virus DNA levels differentiating inactive carriers from patients with chronic hepatitis B. Eur J Gastroenterol Hepatol 2005; 17: 753-757
32. Chen CJ, Yang HL Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73
33. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005; 97: 265-272
34. Iloeje UH, Yang HL Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678-686
35. Luo KX, Zhou R, Liang ZS, Jiang S. Correlation between the prevalence of serum HBV DNA and immunoserologic HBV markers in the subjects with or without hepatitis. Immunol Invest 1992; 21: 275-281
36. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112
37. Bradbury MW. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol 2006; 290: G194-G198
38. Sanyal AJ. Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 46-53
39. Jonas MM. Nonalcoholic fatty liver disease. Adolesc Med Clin 2004; 15: 159-173, xi
40. Wanless IR, Shiota K. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis 2004; 24: 99-106
41. Moritani M, Adachi K, Arima N, Takashima T, Miyaoka Y, Niigaki M, Furuta K, Sato S, Kinoshita Y. A study of arteriosclerosis in healthy subjects with HBV and HCV infection. J Gastroenterol 2005; 40: 1049-1053
42. Desombere I, Willems A, Gijbels Y, Leroux-Roels G. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen. J Virol 2006; 80: 3506-3514
43. Lee YI, Hwang JM, Im. JH, Lee YL Kim NS, Kim DG, Yu DY, Moon HB, Park SK. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J Biol Chem 2004; 279: 15460-15471
44. Huang CF, Lin SS, Ho YC, Chen FL, Yang CC. The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol 2006; 3: 97-106
45. Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 2001; 21: 7721-7730
46. Cottrell DA, Turnbull DM. Mitochondria and ageing. Curr Opin Clin Nutr Metab Care 2000; 3: 473-478
47. Medina J, Fernandez-Salazar LI, Garcia-Buey L, Moreno-Otero R. Approach to the pathogenesis and treatment of non-alcoholic steatohepatitis. Diabetes Care 2004; 27: 2057-2066
48. Zhang X, Zhang H, Ye L. Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med 2006; 147: 58-66
49. Bouchard MJ, Wang LH, Schneider RJ. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 2001; 294: 2376-2378
50. Reddy JK. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2001; 281: G1333-G1339
51. Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 2001; 21: 57-69
52. Pessayre D, Fromenty B, Mansouri A. Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol 2004; 16: 1095-1105
53. Rao MS, Reddy JK. Peroxisomal beta-oxidation and steatohepatitis. Semin Liver Dis 2001; 21: 43-55
54. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999; 12: 351-366